Cargando…
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
Allergen-specific desensitization is the only disease-modifying therapy currently available for the treatment of allergies. These therapies require application of allergen over several years and some may induce life-threatening anaphylactic reactions. An ideal vaccine for desensitization should be h...
Autores principales: | Schmitz, Nicole, Dietmeier, Klaus, Bauer, Monika, Maudrich, Melanie, Utzinger, Stefan, Muntwiler, Simone, Saudan, Philippe, Bachmann, Martin F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737174/ https://www.ncbi.nlm.nih.gov/pubmed/19667059 http://dx.doi.org/10.1084/jem.20090199 |
Ejemplares similares
-
Methods for predicting vaccine immunogenicity and reactogenicity
por: Gonzalez-Dias, Patrícia, et al.
Publicado: (2019) -
Immunogenicity and Reactogenicity in Q Fever Vaccine Development
por: Fratzke, Alycia P., et al.
Publicado: (2022) -
Fel d1 Blocking Antibodies: A Novel Method to Reduce IgE-Mediated Allergy to Cats
por: Satyaraj, Ebenezer, et al.
Publicado: (2021) -
Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines
por: Gonen, Tal, et al.
Publicado: (2023) -
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV
por: Motta, Edwiges, et al.
Publicado: (2023)